Global Cell Expansion Market to Surpass US$ 39,256.2 Million by 2030 - Coherent Market Insight

SEATTLE, Sept. 21, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global Cell Expansion Market is estimated to be valued at US$ 16,035.5 Million in 2022 and is expected to exhibit a CAGR of 11.8% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Cell Expansion Market:

Key trends in market include increasing investment by market players for biotechnology products, increasing product launches by key players, dedication towards stem cell manufacturing by Key market players, etc.

Increasing investments by market players for biotechnology products related to cell and gene therapy is expected to fuel the growth of global cell expansion market over the forecast period. For instance, in February 2022, FUJIFILM Corporation, a Japan-based multinational conglomerate, announced the launch of its life sciences strategic investment fund, which will be administered by the Life Sciences Corporate Venture Capital (LS-CVC), a newly established organization under Fujifilm's Life Sciences Strategy Headquarters in Tokyo. Fujifilm is investing US$ 54 million, which will focus on cutting-edge biotechnology through partnerships with early-stage enterprises, globally. In addition to this new fund, the LS-CVC is taking over management of the company's previous life science investment portfolio, which included investments in regenerative medicine, cell therapies, and drug development research products.

Increasing number of product launches related to anti-microbial therapies is expected to drive the growth of global cell expansion market over forecast period. For instance, in October 2020, Merck, a global leader in research and technology, launched a new VirusExpress Lentiviral Production Platform, based on Merck's experience as a contract development and manufacturing firm. This new platform can overcome lentiviral production hurdles and cut process development time by around 40%. Merck's VirusExpress Platform streamlines the upstream process, making cell and gene therapy development easier to manage, alter, and scale.

Request for Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1293

Introduction of dedicated stem cell manufacturing and expansion facilities is expected to drive the growth of global cell expansion market over forecast period. For instance, in April 2022, Ncardia, a leader in contract research, development, and manufacturing of induced pluripotent stem cell (iPSC)-based solutions launched Cellistic, an iPSC cell therapy CDMO (Contract Development and Manufacturing Organization). Cellistic focuses on the development and manufacturing of human iPSC-based cell therapies. Celletic's expertise and focus on iPSC reprogramming, differentiation, and expansion protocol makes it an ideal partner for innovative cell therapy developers looking to commercialize novel advanced therapies.

Key Market Takeaways:

Market players are involved in launching of automated cell mass culture equipment, and is further expected to drive growth of the global cell expansion market, over the forecast period. For instance, in March 2019, Hitachi, Ltd., a Japan-based multinational company, announced the launch of automated cell mass culture equipment in Japan, which will be used to produce commercial induced pluripotent stem (iPS) cells for regenerative medicine.

Among regions, North America is expected to hold a dominant position in the global cell expansion market over the forecast period, owing to increasing product launch in the region. In July 2020, Corning Incorporated, a multinational technology company based in the U.S., announced the launch of Corning X-SERIES cell processing platform. The platform allows for rapid, sterile, automated, and efficient processing of human blood and blood products, in order to obtain purified immune cell populations for cell and gene therapy applications.

Key players operating in the global cell expansion market include Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1293

Detailed Segmentation:

Global Cell Expansion Market, By Product:

• Consumables
• Media
• Others
• Instruments
• Automated Cell
• Expansion Systems
• Cell Counters
• Centrifuges
• Bioreactors
• Others
• Accessories

Global Cell Expansion Market, By Cell Type:

• Mammalian Cells
• Human Cells
• Stem Cells
• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells
• Differentiated Cells
• Animal Cells
• Microbial Cells
• Others (Plant-derived Cells)

Global Cell Expansion Market, By Application:

• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Cancer Research
• Stem Cell Research
• Other Applications

Global Cell Expansion Market, By End User:

• Biotechnology Companies
• Biopharmaceutical Companies
• Others

Global Cell Expansion Market, By Region:

• North America
• By Country:
• U.S.
• Canada
• Europe
• By Country:
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country:
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• By Country:
• GCC Countries
• Israel
• South Africa
• Rest of Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/1293

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us: 
Mr. Shah 
Senior Client Partner – Business Development 
Coherent Market Insights 
Phone: 
US: +1-206-701-6702 
UK: +44-020-8133-4027 
Japan: +81-050-5539-1737 
India: +91-848-285-0837 
Email: [email protected] 
Website: https://www.coherentmarketinsights.com 
Follow Us: LinkedIn | Twitter

Logo : https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

SOURCE Coherent Market Insights